Literature DB >> 26148973

Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.

Xavier C Giner1, David Cotnoir-White1, Sylvie Mader1, Daniel Lévesque2.   

Abstract

Retinoid X receptors (RXRs) play a role as master regulators because of their capacity to form heterodimers with other nuclear receptors (NRs). Accordingly, retinoid signaling is involved in multiple biologic processes, including development, cell differentiation, metabolism, and cell death. However, the role and function of RXRs in different heterodimer complexes remain unidentified, mainly because most RXR drugs (called rexinoids) are not selective of specific heterodimer complexes. The lack of selectivity strongly limits the use of rexinoids for specific therapeutic approaches. To better characterize rexinoids at specific NR complexes, we have developed and optimized luciferase (Luc) protein complementation(PCA)-based bioluminescence resonance energy transfer (BRET) assays that can directly measure recruitment of a coactivator (CoA) motif fused to yellow fluorescent protein (YFP) by specific NR dimers. To validate the assays, we compared rexinoid modulation of CoA recruitment by the RXR homodimer and by the heterodimers Nur77/RXR and Nurr1/RXR. Results revealed that some rexinoids display selective CoA recruitment activities with homo- or heterodimer complexes. In particular, SR11237 (BMS649) has stronger potency for recruitment of CoA motif and transcriptional activity with the heterodimer Nur77/RXR than other complexes. This technology should be useful in identifying new compounds with specificity for individual dimeric species formed by NRs. © FASEB.

Entities:  

Keywords:  cofactor recruitment; nuclear receptors; pharmacological parameters; protein conformation; receptor dimerization

Mesh:

Substances:

Year:  2015        PMID: 26148973      PMCID: PMC5346306          DOI: 10.1096/fj.14-259804

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  60 in total

Review 1.  Principles for modulation of the nuclear receptor superfamily.

Authors:  Hinrich Gronemeyer; Jan-Ake Gustafsson; Vincent Laudet
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 2.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation.

Authors:  Daniel Lévesque; Claude Rouillard
Journal:  Trends Neurosci       Date:  2006-11-28       Impact factor: 13.837

Review 3.  Design of selective nuclear receptor modulators: RAR and RXR as a case study.

Authors:  Angel R de Lera; William Bourguet; Lucia Altucci; Hinrich Gronemeyer
Journal:  Nat Rev Drug Discov       Date:  2007-10       Impact factor: 84.694

4.  Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.

Authors:  Virginie Nahoum; Efrén Pérez; Pierre Germain; Fátima Rodríguez-Barrios; Fabio Manzo; Sabrina Kammerer; Geraldine Lemaire; Oliver Hirsch; Catherine A Royer; Hinrich Gronemeyer; Angel R de Lera; William Bourguet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-18       Impact factor: 11.205

5.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

Review 6.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

7.  Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation.

Authors:  M Maira; C Martens; A Philips; J Drouin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

8.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

9.  Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).

Authors:  Carl E Wagner; Peter W Jurutka; Pamela A Marshall; Thomas L Groy; Arjan van der Vaart; Joseph W Ziller; Julie K Furmick; Mark E Graeber; Erik Matro; Belinda V Miguel; Ivy T Tran; Jungeun Kwon; Jamie N Tedeschi; Shahram Moosavi; Amina Danishyar; Joshua S Philp; Reina O Khamees; Jevon N Jackson; Darci K Grupe; Syed L Badshah; Justin W Hart
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

10.  Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.

Authors:  M F Boehm; L Zhang; L Zhi; M R McClurg; E Berger; M Wagoner; D E Mais; C M Suto; J A Davies; R A Heyman
Journal:  J Med Chem       Date:  1995-08-04       Impact factor: 7.446

View more
  9 in total

Review 1.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

2.  Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models.

Authors:  Stephanie Kim; Amy Li; Stefano Monti; Jennifer J Schlezinger
Journal:  Arch Toxicol       Date:  2018-07-19       Impact factor: 5.153

3.  NURR1 expression regulates retinal pigment epithelial-mesenchymal transition and age-related macular degeneration phenotypes.

Authors:  Pei-Li Yao; Vipul M Parmar; Mayur Choudhary; Goldis Malek
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-08       Impact factor: 12.779

4.  Agonist binding directs dynamic competition among nuclear receptors for heterodimerization with retinoid X receptor.

Authors:  Lina Fadel; Bálint Rehó; Julianna Volkó; Dóra Bojcsuk; Zsuzsanna Kolostyák; Gergely Nagy; Gabriele Müller; Zoltan Simandi; Éva Hegedüs; Gábor Szabó; Katalin Tóth; Laszlo Nagy; György Vámosi
Journal:  J Biol Chem       Date:  2020-06-08       Impact factor: 5.157

5.  Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization.

Authors:  Marcel Scheepstra; Sebastian A Andrei; Rens M J M de Vries; Femke A Meijer; Jian-Nong Ma; Ethan S Burstein; Roger Olsson; Christian Ottmann; Lech-Gustav Milroy; Luc Brunsveld
Journal:  ACS Chem Neurosci       Date:  2017-07-24       Impact factor: 4.418

Review 6.  Targeting Smoothened as a New Frontier in the Functional Recovery of Central Nervous System Demyelinating Pathologies.

Authors:  Alice Del Giovane; Antonella Ragnini-Wilson
Journal:  Int J Mol Sci       Date:  2018-11-20       Impact factor: 5.923

7.  EGFR/ErbB Inhibition Promotes OPC Maturation up to Axon Engagement by Co-Regulating PIP2 and MBP.

Authors:  Emanuela Nocita; Alice Del Giovane; Marta Tiberi; Laura Boccuni; Denise Fiorelli; Carola Sposato; Elena Romano; Francesco Basoli; Marcella Trombetta; Alberto Rainer; Enrico Traversa; Antonella Ragnini-Wilson
Journal:  Cells       Date:  2019-08-06       Impact factor: 6.600

8.  Comprehensive assessment of NR ligand polypharmacology by a multiplex reporter NR assay.

Authors:  Alexander Medvedev; Matt Moeser; Liubov Medvedeva; Elena Martsen; Alexander Granick; Lydia Raines; Kristen Gorman; Benjamin Lin; Ming Zeng; Keith A Houck; Sergei S Makarov
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.996

9.  Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.

Authors:  Marie V Coignet; Gary Robert Zirpoli; Michelle R Roberts; Thaer Khoury; Elisa V Bandera; Qianqian Zhu; Song Yao
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.